Pyrantel in small animal medicine: 30 years on.
Pyrantel, a tetrahydropyrimidine nicotinic agonist anthelmintic, has been used in companion animal medicine since the 1970s to control two important nematode groups, the hookworms and the roundworms. Given the zoonotic potential of these parasites, pyrantel has served a dual role in helping to protect the health of both companion animals and the public for more than 30 years. This review describes the history and mechanism of action of this drug, and collates evidence that resistance to pyrantel has developed in at least one canine nematode, the hookworm Ancylostoma caninum. The role of in vitro diagnosis tests in managing anthelmintic resistance in companion animal parasites is discussed, as are management practices that may reduce the rate at which resistance develops.
Kopp
Steven R
SR
School of Veterinary Science, University of Queensland, 4072 Queensland, Australia.
Kotze
Andrew C
AC
McCarthy
James S
JS
Traub
Rebecca J
RJ
Coleman
Glen T
GT
D000818:Animals; D000969:Antinematodal Agents / Q000627:therapeutic use*; D002371:Cat Diseases / Q000188:drug therapy* / Q000469:parasitology*; D002415:Cats; D004283:Dog Diseases / Q000188:drug therapy* / Q000469:parasitology*; D004285:Dogs; D009348:Nematoda / Q000254:growth & development; D009349:Nematode Infections / Q000188:drug therapy / Q000469:parasitology / Q000662:veterinary*; D011715:Pyrantel / Q000627:therapeutic use*
D000969:Antinematodal Agents; D011715:Pyrantel